When does Newron report earnings and why does it matter for NWRN.SW stock?

Newron reports on 24 Mar 2026. The earnings release and conference call will update revenue, R&D spend and clinical milestones, which typically move NWRN.SW stock intraday and reshape near‑term guidance.

What valuation metrics should investors watch for NWRN.SW stock?

Key metrics: trailing EPS **1.23**, PE **11.87**, price/sales **5.34**, and cash per share **2.16**. Compare these with Healthcare peers and monitor any guidance changes at earnings.

What is Meyka AI's forecast for NWRN.SW stock and what does it imply?

Meyka AI's forecast model projects **CHF 23.38** in 12 months. Versus the current **CHF 15.40**, that implies about **51.84%** upside. Forecasts are model‑based projections and not guarantees.

How should traders approach intraday moves in NWRN.SW stock ahead of earnings?

Expect higher volatility: RSI **20.12** and ATR **1.08** indicate wide price swings. Use smaller position sizes, defined stop losses and listen to the earnings call for immediate guidance or pipeline updates.

CH Stocks

Earnings due 24 Mar: NWRN.SW Newron Pharmaceuticals S.p.A. (SIX) pipeline test

ByDanny Kontos March 23, 2026March 23, 2026

The NWRN.SW stock trades intraday at CHF 15.40 as investors prepare for Newron Pharmaceuticals S.p.A.’s earnings on 24 Mar 2026. Traders will watch revenue, pipeline updates and guidance. Intraday volume is 140,163 shares and the move today links directly to upcoming clinical milestones and the company’s valuation on the SIX exchange in Switzerland.